Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Open Access
- 11 December 2024
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (1) , 10.e1-10.e9
Abstract
No abstract availableKeywords
Funding Information
- California Department of Fish and Game (B13)
- National Cancer Institute (P01 CA039542)
- National Cancer Institute (P30 CA196521)
- Pediatric Cancer Foundation
- José Carreras Leukämie-Stiftung
- National Institutes of Health
- Deutsche Forschungsgemeinschaft
- Pfizer
- Else Kröner-Fresenius-Stiftung
This publication has 26 references indexed in Scilit:
- A Day 14 Endpoint for Acute GVHD Clinical TrialsTransplantation and Cellular Therapy, 2024
- Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationThe Lancet Haematology, 2024
- Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisNew England Journal of Medicine, 2023
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2016
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related MortalityTransplantation and Cellular Therapy, 2015
- First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2012
- Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint StatementTransplantation and Cellular Therapy, 2009
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study DesignJNCI: Journal of the National Cancer Institute, 2008
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIALBiometrika, 1934